Jobs
-
Inhaler test equipment manufacturer Copley Scientific has launched The TPK 2100, a new model in its TPK series of critical flow controllers for the testing of dry powder inhalers. The company is also launching a… Read more . . .
-
DDL2017 delegates are being targeted by scammers, organizers warn. Callers claiming to be from the DDL organization have been phoning delegates and offering to book accommodations for the conference and then ask for credit card… Read more . . .
-
Pulmatrix has announced that its PUR1900 itraconazole DPI has received Qualified Infectious Disease Product (QIDP) designation for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in asthma patients. PUR1900 received Orphan Drug designation in 2016 and… Read more . . .
-
Intranasal drug developer Impel NeuroPharma has announced the appointment of former Nivalis Therapeutics leader Jon Congleton as the company’s new President and Chief Executive Officer (CEO). Congleton was most recently President and CEO of Nivalis… Read more . . .
-
The 700-plus OINDP specialists expected to convene at the Edinburgh International Conference Centre December 6-8 for this year’s Drug Delivery to the Lungs (DDL) meeting will notice a few small changes designed to further the… Read more . . .
-
Synairgen has announced that it is considering development of its SNG001 inhaled interferon beta for the treatment of COPD. SNG001 was previously in development for the prevention of exacerbations caused by viral lung infections in… Read more . . .
-
CDMO Micro-Sphere has added a Harro Höfliger Modu-C MS capsule filling machine at its Lugano, Switzerland facility as part of a €19 million expansion, the company said, adding that the new machine offers 100% check… Read more . . .
-
Engage Therapeutics has closed a $23 million Series A financing round led by TPG Biotech that will fund a Phase 2b clinical trial of an inhaled alprazolam for the treatment of acute epileptic seizures. Alexza… Read more . . .
-
CDMO and device company Hovione has announced the appointment of Frédéric Kahn as VP Marketing and Sales. Kahn most recently served as VP Global Head of Key Account Management at Lonza and previously held executive… Read more . . .
-
Savara has announced the initiation of a Phase 3 study of its AeroVanc vancomycin DPI for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) lung infections in cystic fibrosis patients. The AVAIL study is expected to… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA